FGF9 and metabolic dysfunction-associated steatohepatitis: To further explore the correlation between the differentially expressed genes (DEGs) related to FGF9 overexpression and NASH, we overlapped our transcriptome data with previously reported hepatic transcriptome data from the mouse model of NASH‐driven HCC.[28] A total of 902 and 577 DEGs were identified in mice with NASH‐driven HCC (GSE95140, p<0.01) and FGF9‐overexpressing Huh7 cells (p<0.01), respectively, compared to their respective controls.